Want to see IN:ASTRAZEN full AI Analyst Report?
Total Valuation
AstraZeneca Pharma India Limited has a market cap or net worth of ₹193.84B. The enterprise value is ₹190.61K.
Market Cap₹193.84B
Enterprise Value₹190.61K
Share Statistics
AstraZeneca Pharma India Limited has 25,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding25,000,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AstraZeneca Pharma India Limited’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 17.00%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)17.00%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee29.94M
Profits Per Employee2.47M
Employee Count760
Asset Turnover1.14
Inventory Turnover1.63
Valuation Ratios
The current PE Ratio of AstraZeneca Pharma India Limited is 112.6. AstraZeneca Pharma India Limited’s PEG ratio is 1.67.
PE Ratio112.6
PS Ratio8.53
PB Ratio22.24
Price to Fair Value22.24
Price to FCF6.05K
Price to Operating Cash Flow-290.60
PEG Ratio1.67
Income Statement
In the last 12 months, AstraZeneca Pharma India Limited had revenue of 22.76B and earned 1.88B in profits. Earnings per share was 75.01.
Revenue22.76B
Gross Profit6.02B
Operating Income2.33B
Pretax Income2.52B
Net Income1.88B
EBITDA2.85B
Earnings Per Share (EPS)75.01
Cash Flow
In the last 12 months, operating cash flow was -657.30M and capital expenditures -2.90M, giving a free cash flow of -660.20M billion.
Operating Cash Flow-657.30M
Free Cash Flow-660.20M
Free Cash Flow per Share-26.41
Dividends & Yields
AstraZeneca Pharma India Limited pays an annual dividend of ₹36, resulting in a dividend yield of 0.47%
Dividend Per Share₹36
Dividend Yield0.47%
Payout Ratio40.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change-8.92%
50-Day Moving Average8.17K
200-Day Moving Average8.54K
Relative Strength Index (RSI)36.58
Average Volume (3m)602.00
Important Dates
AstraZeneca Pharma India Limited upcoming earnings date is Nov 14, 2026, TBA (Confirmed).
Last Earnings DateAug 10, 2026
Next Earnings DateNov 14, 2026
Ex-Dividend Date―
Financial Position
AstraZeneca Pharma India Limited as a current ratio of 1.77, with Debt / Equity ratio of 0.00%
Current Ratio1.77
Quick Ratio0.73
Debt to Market Cap<0.01
Net Debt to EBITDA-1.18
Interest Coverage Ratio51.99
Taxes
In the past 12 months, AstraZeneca Pharma India Limited has paid 646.80M in taxes.
Income Tax646.80M
Effective Tax Rate0.26
Enterprise Valuation
AstraZeneca Pharma India Limited EV to EBITDA ratio is 66.87, with an EV/FCF ratio of 5.94K.
EV to Sales8.38
EV to EBITDA66.87
EV to Free Cash Flow5.94K
EV to Operating Cash Flow2.80K
Balance Sheet
AstraZeneca Pharma India Limited has ₹4.48B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹4.48B billion.
Cash & Marketable Securities₹4.48B
Total Debt₹0.00
Net Cash₹4.48B
Net Cash Per Share₹179.09
Tangible Book Value Per Share₹349.13
Margins
Gross margin is 31.41%, with operating margin of 10.26%, and net profit margin of 8.24%.
Gross Margin31.41%
Operating Margin10.26%
Pretax Margin11.08%
Net Profit Margin8.24%
EBITDA Margin12.54%
EBIT Margin11.28%
Analyst Forecast
The average price target for AstraZeneca Pharma India Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast31.10%
EPS Growth Forecast-7.49%